Treatment Action Group Statement on Bedaquiline Unaffordability
July 6, 2020 — Treatment Action Group welcomes the Global Drug Facility / Stop TB Partnership’s negotiation of what amounts to a 32% savings on bedaquiline, the backbone of improved, all-oral regimens for treating drug-resistant TB.
Public Health Organizations Call on NYC Board of Health to Declare Racism and Over-Policing of Black and Latinx New Yorkers a Public Health Emergency
June 26, 2020 — Several prominent community health organizations with decades of experience in HIV/AIDS advocacy today served the New York City Board of Health with a formal petition calling for an emergency meeting to address racism and over-policing of Black and Latinx communities as concurrent, city-wide public health emergencies.
Treatment Action Group Commemorates Juneteenth through Solidarity Actions, Reflection, and Transparency
June 18, 2020 — Tomorrow, Treatment Action Group (TAG) will be observing and honoring Juneteenth—a commemoration of the end of slavery in the United States—through a day of solidarity, actions, and reflection.
Treatment Action Group Mourns and Resists Violence towards Black Communities; Demands Action and Accountability across Government and Systems
June 5, 2020 — Treatment Action Group (TAG) joins partners, activists, and communities around the U.S. and the world in decrying violence against Black people and those who stand in solidarity with them.
In Memoriam – Larry Kramer
May 27, 2020 — Treatment Action Group (TAG) is deeply saddened to learn that the seemingly indestructible writer, activist, playwright, and agitator Larry Kramer has died at 84.
Long-Acting Injectable Cabotegravir for HIV Pre-Exposure Prophylaxis (PrEP): Promising Results from HPTN 083
May 19, 2020 — Treatment Action Group (TAG) welcomes the news that long-acting injectable cabotegravir (CAB LA, from ViiV Healthcare) demonstrated a high level of efficacy for preventing HIV infection in cisgender men and transgender women who have sex with men in the HIV Prevention Trials Network (HPTN) 083 trial.
AVAC and TAG Statement on Ethical Conduct of SARS-CoV-2 Vaccine Challenge Studies
May 7, 2020 — The COVID-19 pandemic is a global health emergency that may demand new, safe, and expedited ways of conducting ethical research to find the solutions we need, including a safe and effective vaccine.
Treatment Action Group and the PrEP4All Collaboration Respond to Reported Remdesivir Results for COVID-19
April 30, 2020 — Treatment Action Group (TAG) and the PrEP4All Collaboration welcome results from randomized controlled trials of therapies for COVID-19, but are seriously concerned about claims that data from a National Institutes of Allergy and Infectious Diseases (NIAID) study of the Gilead drug remdesivir…
Global Health and Human Rights Organizations Denounce Trump Administration Decision to Pull Commitments to WHO during COVID-19 Crisis
April 16, 2020 — AVAC, Health GAP, Knowledge Ecology International (KEI), and Treatment Action Group (TAG) strongly condemn the Trump Administration’s decision to halt funding to the World Health Organization (WHO) in the midst of the urgent COVID-19 global health crisis.
Treatment Action Group Celebrates New Guidance on the Right to Science by Global Human Rights Body
April 14, 2020 — Treatment Action Group (TAG) celebrates publication of the General Comment on “the human right of everyone to participate in and to enjoy the benefits of scientific progress and its applications” (the right to science), and calls the attention of grassroots activists and global civil society working on health to this…